NCT06428110View on ClinicalTrials.gov

A Prospective Cohort Study on Warfarin Personalized Medication

CompletedOBSERVATIONAL
Enrollment

272

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 12, 2023

Study Completion Date

December 12, 2023

Conditions
Warfarin Sodium Causing Adverse Effects in Therapeutic Use
Interventions
OTHER

Trial Locations (1)

200240

The Fifth People's Hospital of Shanghai, Shanghai

All Listed Sponsors
lead

Haobin Li

OTHER

NCT06428110 - A Prospective Cohort Study on Warfarin Personalized Medication | Biotech Hunter | Biotech Hunter